Success story
A BioScience company was looking to explore reactions towards a new Alzheimer's treatment and commissioned Turquoise to conduct research to explore initial perceptions and reactions towards this new product amongst HCPs within the USA and UK.
"
Turquoise conducted an online survey with respondents who were selected from a specialist Health Care Professional panel. A sample of 65 respondents was achieved, all of whom were medically qualified and practising in the USA and UK. The questionnaire focused on attitudes towards exiting Alzheimer's Disease medications and reactions towards the new product.
Alongside the high level of general dissatisfaction with current Alzheimer’s Disease treatments amongst HCP’s, we also noted the dissatisfaction with current poor testing of early detection.
The new product was received with 80% positive response and was generally viewed as an improvement over current medication. A pricing sensitivity exercise within the research also provided guidelines on potential pricing strategies within both the UK and USA.
Our unique approach
Whether we are helping pharmaceutical companies understand and predict customer behaviour, powering smarter data-driven strategy, or driving organisational change, our unique model helps deliver scientifically superior results for the whole industry.
Know what consumers think, better than they know themselves. Our model uniquely unearths subconscious psychological factors that influence customer feelings and behaviours.
Our model validates deeper methodological and contextual factors behind the data, not just the data itself, which helps uncover truly relevant insight while minimising noise.
Our unique model allows pharmaceutical companies to accurately predict market and customer behaviour, helping to power genuinely forward-thinking strategy and decision making.
